Toxoplasma gondii, HCV, and HBV Seroprevalence in Haemodialysis Patients with Chronic Renal Failure in Al-Kindy Hospital Baghdad, Iraqi | ||
Al-Mustansiriyah Journal of Science | ||
Article 1, Volume 23, Issue 5, July 2012, Pages 33-38 | ||
Author | ||
Sura Basil Kamal Al-Dulaimi | ||
Abstract | ||
This study aimed to determine the seroprevalence of Toxoplasma gondii and anti HCV antibodies , HBVs Ag in patients with chronic renal failure (CRF) before and after hemodialysis, Serum samples were taken from 152 patients with CRF in addition to 28 healthy controls. patients were classified into two groups, The first group comprised 68 patients with CRF who haven’t any hemodialysis session, The second group comprised 84 patients with CRF undergoing regular hemodialysis . T.gondii antibodies were detected in(44.1%) of the first group and (80.9%) in the second group and (57.1%) in the healthy control.From the present results it was noticed high percentage of positivity of toxoplasma antibodies in patients with CRF undergoing hemodialysis also we determined that out of 84 CRF patients undergoing hemodialysis (14.3%) were positive for Anti-HCV the same for Anti HBVs Ag. So it can be concluded that CRF patients undergoing hemodialysis shoud be screened for toxoplasma ,HCV and HBVs Ag before dialysis to prevent the dissemination of these infections through dialysis procedure | ||
Statistics Article View: 7 PDF Download: 2 |